Clinical Trials Browser

Phase 2 × Primary Myelofibrosis × SB939 compound × Clear all

NCT02267278 2019-06-12

Ruxolitinib and Pracinostat Combination Therapy for Patients With Myelofibrosis (MF)

Phase 2 Completed

25 enrolled 8 charts

Polycythemia Vera, Primary Myelofibrosis